Prosthetic Heart Valve Market Size, Share and Growth Outlook 2026: By Valve Type, By Position, By Delivery Method, By End-User, Companies to 2034
The global Prosthetic Heart Valve Market size is forecast to increase from $14.33 Billion in 2026 to $37.03 Billion in 2034 at a CAGR of 12.6% between 2026 and 2034.
The Prosthetic Heart Valve market report provides detailed analysis and outlook of Prosthetic Heart Valve segments including By Valve Type (Transcatheter Heart Valves, Mechanical Heart Valves, Tissue/Bioprosthetic Heart Valves, Sutureless Heart Valves, Polymeric/Next-Gen Heart Valves), By Position (Aortic, Mitral, Tricuspid, Pulmonary), By Delivery Method (Surgical, Transcatheter, Sutureless/Rapid-deployment), By End-User (Hospitals, Cardiac Specialty Centers, Ambulatory Surgical Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Prosthetic Heart Valve Industry Overview
Transcatheter Expansion, Tissue Durability Innovation, and AI-Driven Patient Identification Are Reshaping the Prosthetic Heart Valve Market
The prosthetic heart valve industry is undergoing a major transformation driven by advances in transcatheter valve therapies, long-term tissue durability technologies, and artificial intelligence-enabled patient identification platforms. Clinical practice continues to shift away from conventional open surgical interventions toward minimally invasive structural heart procedures capable of treating increasingly complex patient populations. Simultaneously, manufacturers are investing heavily in anti-calcification technologies, expanded transcatheter indications, and digital diagnostic infrastructure to improve patient outcomes, reduce procedural risk, and expand access to valve replacement therapies.
Long-Term Tissue Durability Is Becoming a Key Competitive Differentiator
As prosthetic heart valves are increasingly implanted in younger and more active patient populations, long-term structural durability and resistance to calcification have become critical performance metrics. Manufacturers continue to develop advanced biomaterial technologies designed to maximize valve longevity while minimizing reintervention requirements. This trend is demonstrated by the 10-year clinical data released by Edwards Lifesciences from its COMMENCE surgical aortic valve trial. The findings showed 97.9% freedom from structural valve deterioration and 97.8% freedom from reoperation due to structural valve deterioration, validating the long-term performance of the company's RESILIA tissue technology. The proprietary calcium-blocking and dry-storage platform has subsequently been integrated across both surgical and transcatheter valve portfolios, reinforcing the industry's focus on extending prosthetic valve lifespan.
Transcatheter Structural Heart Therapies Are Expanding Into Complex Valve Disease
The prosthetic heart valve market continues to expand beyond transcatheter aortic valve replacement into increasingly challenging structural heart interventions. Minimally invasive treatment options are becoming available for patient populations previously considered unsuitable for intervention. This trend is exemplified by the FDA approval of the SAPIEN M3 transcatheter mitral valve replacement system developed by Edwards Lifesciences. The fully percutaneous, transseptal therapy represents the first approved transcatheter mitral valve replacement platform for patients with severe mitral regurgitation who are ineligible for surgery or transcatheter edge-to-edge repair. Utilizing a specialized docking system followed by implantation of a bovine pericardial tissue valve, the system demonstrated elimination of severe mitral regurgitation in 95.7% of treated patients, highlighting the continued expansion of catheter-based structural heart therapies.
Artificial Intelligence Is Improving Valve Disease Identification and Treatment Access
The growing adoption of artificial intelligence and digital screening technologies is helping address the persistent underdiagnosis of structural heart disease. Healthcare systems increasingly deploy automated clinical decision support tools to identify untreated patients who may benefit from valve interventions. This trend is illustrated by the clinical results presented by Medtronic plc from its ALERT Trial. Using the Tempus Next AI platform to analyze echocardiographic data within electronic health record systems, the study demonstrated that automated clinician notifications increased transcatheter aortic valve replacement procedures by 40% and multidisciplinary heart team evaluations by 27% within 90 days. These findings reinforce the growing role of artificial intelligence in expanding patient access to advanced prosthetic heart valve therapies.
Prosthetic Heart Valve Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Prosthetic Heart Valve market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Livanova PLC, CryoLife, Inc. (Artivion, Inc.), Meril Life Sciences Pvt. Ltd., Lepu Medical Technology (Beijing) Co., Ltd., JenaValve Technology, Inc., Anteris Technologies Ltd.. The Prosthetic Heart Valve market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Prosthetic Heart Valve industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Prosthetic Heart Valve industry include- Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Livanova PLC, CryoLife, Inc. (Artivion, Inc.), Meril Life Sciences Pvt. Ltd., Lepu Medical Technology (Beijing) Co., Ltd., JenaValve Technology, Inc., Anteris Technologies Ltd.. The Prosthetic Heart Valve market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Prosthetic Heart Valve Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Prosthetic Heart Valve market remains one of the strongest-performing segments in the country.
The US Prosthetic Heart Valve Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Prosthetic Heart Valve market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Prosthetic Heart Valve industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Prosthetic Heart Valve markets
Canada's strong Prosthetic Heart Valve sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Prosthetic Heart Valve market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Prosthetic Heart Valve Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Prosthetic Heart Valve market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Prosthetic Heart Valve population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Prosthetic Heart Valve industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Prosthetic Heart Valve market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Prosthetic Heart Valve sales through 2034
France Prosthetic Heart Valve companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Prosthetic Heart Valve Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Prosthetic Heart Valve distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Prosthetic Heart Valve Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Prosthetic Heart Valve market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Prosthetic Heart Valve industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Prosthetic Heart Valve industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Prosthetic Heart Valve Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Prosthetic Heart Valve market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Prosthetic Heart Valve market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Prosthetic Heart Valve Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Prosthetic Heart Valve Market Segmentation
By Valve Type
Transcatheter Heart Valves
Mechanical Heart Valves
Tissue/Bioprosthetic Heart Valves
Sutureless Heart Valves
Polymeric/Next-Gen Heart Valves
By Position
Aortic
Mitral
Tricuspid
Pulmonary
By Delivery Method
Surgical
Transcatheter
Sutureless/Rapid-deployment
By End-User
Hospitals
Cardiac Specialty Centers
Ambulatory Surgical Centers
Leading Companies in Prosthetic Heart Valve Industry (2026)
Edwards Lifesciences Corporation
Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
Livanova PLC
CryoLife, Inc. (Artivion, Inc.)
Meril Life Sciences Pvt. Ltd.
Lepu Medical Technology (Beijing) Co., Ltd.
JenaValve Technology, Inc.
Anteris Technologies Ltd.
Countries Included
The Prosthetic Heart Valve market report provides detailed analysis and outlook of Prosthetic Heart Valve segments including By Valve Type (Transcatheter Heart Valves, Mechanical Heart Valves, Tissue/Bioprosthetic Heart Valves, Sutureless Heart Valves, Polymeric/Next-Gen Heart Valves), By Position (Aortic, Mitral, Tricuspid, Pulmonary), By Delivery Method (Surgical, Transcatheter, Sutureless/Rapid-deployment), By End-User (Hospitals, Cardiac Specialty Centers, Ambulatory Surgical Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Prosthetic Heart Valve Industry Overview
Transcatheter Expansion, Tissue Durability Innovation, and AI-Driven Patient Identification Are Reshaping the Prosthetic Heart Valve Market
The prosthetic heart valve industry is undergoing a major transformation driven by advances in transcatheter valve therapies, long-term tissue durability technologies, and artificial intelligence-enabled patient identification platforms. Clinical practice continues to shift away from conventional open surgical interventions toward minimally invasive structural heart procedures capable of treating increasingly complex patient populations. Simultaneously, manufacturers are investing heavily in anti-calcification technologies, expanded transcatheter indications, and digital diagnostic infrastructure to improve patient outcomes, reduce procedural risk, and expand access to valve replacement therapies.
Long-Term Tissue Durability Is Becoming a Key Competitive Differentiator
As prosthetic heart valves are increasingly implanted in younger and more active patient populations, long-term structural durability and resistance to calcification have become critical performance metrics. Manufacturers continue to develop advanced biomaterial technologies designed to maximize valve longevity while minimizing reintervention requirements. This trend is demonstrated by the 10-year clinical data released by Edwards Lifesciences from its COMMENCE surgical aortic valve trial. The findings showed 97.9% freedom from structural valve deterioration and 97.8% freedom from reoperation due to structural valve deterioration, validating the long-term performance of the company's RESILIA tissue technology. The proprietary calcium-blocking and dry-storage platform has subsequently been integrated across both surgical and transcatheter valve portfolios, reinforcing the industry's focus on extending prosthetic valve lifespan.
Transcatheter Structural Heart Therapies Are Expanding Into Complex Valve Disease
The prosthetic heart valve market continues to expand beyond transcatheter aortic valve replacement into increasingly challenging structural heart interventions. Minimally invasive treatment options are becoming available for patient populations previously considered unsuitable for intervention. This trend is exemplified by the FDA approval of the SAPIEN M3 transcatheter mitral valve replacement system developed by Edwards Lifesciences. The fully percutaneous, transseptal therapy represents the first approved transcatheter mitral valve replacement platform for patients with severe mitral regurgitation who are ineligible for surgery or transcatheter edge-to-edge repair. Utilizing a specialized docking system followed by implantation of a bovine pericardial tissue valve, the system demonstrated elimination of severe mitral regurgitation in 95.7% of treated patients, highlighting the continued expansion of catheter-based structural heart therapies.
Artificial Intelligence Is Improving Valve Disease Identification and Treatment Access
The growing adoption of artificial intelligence and digital screening technologies is helping address the persistent underdiagnosis of structural heart disease. Healthcare systems increasingly deploy automated clinical decision support tools to identify untreated patients who may benefit from valve interventions. This trend is illustrated by the clinical results presented by Medtronic plc from its ALERT Trial. Using the Tempus Next AI platform to analyze echocardiographic data within electronic health record systems, the study demonstrated that automated clinician notifications increased transcatheter aortic valve replacement procedures by 40% and multidisciplinary heart team evaluations by 27% within 90 days. These findings reinforce the growing role of artificial intelligence in expanding patient access to advanced prosthetic heart valve therapies.
Prosthetic Heart Valve Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Prosthetic Heart Valve market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Livanova PLC, CryoLife, Inc. (Artivion, Inc.), Meril Life Sciences Pvt. Ltd., Lepu Medical Technology (Beijing) Co., Ltd., JenaValve Technology, Inc., Anteris Technologies Ltd.. The Prosthetic Heart Valve market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Prosthetic Heart Valve industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Prosthetic Heart Valve Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Prosthetic Heart Valve companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Prosthetic Heart Valve markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Prosthetic Heart Valve industry include- Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Livanova PLC, CryoLife, Inc. (Artivion, Inc.), Meril Life Sciences Pvt. Ltd., Lepu Medical Technology (Beijing) Co., Ltd., JenaValve Technology, Inc., Anteris Technologies Ltd.. The Prosthetic Heart Valve market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Prosthetic Heart Valve Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Prosthetic Heart Valve market remains one of the strongest-performing segments in the country.
The US Prosthetic Heart Valve Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Prosthetic Heart Valve market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Prosthetic Heart Valve industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Prosthetic Heart Valve markets
Canada's strong Prosthetic Heart Valve sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Prosthetic Heart Valve market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Prosthetic Heart Valve Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Prosthetic Heart Valve market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Prosthetic Heart Valve population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Prosthetic Heart Valve industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Prosthetic Heart Valve market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Prosthetic Heart Valve sales through 2034
France Prosthetic Heart Valve companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Prosthetic Heart Valve Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Prosthetic Heart Valve distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Prosthetic Heart Valve Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Prosthetic Heart Valve market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Prosthetic Heart Valve industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Prosthetic Heart Valve industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Prosthetic Heart Valve Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Prosthetic Heart Valve market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Prosthetic Heart Valve market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Prosthetic Heart Valve Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Prosthetic Heart Valve Market Segmentation
By Valve Type
Transcatheter Heart Valves
Mechanical Heart Valves
Tissue/Bioprosthetic Heart Valves
Sutureless Heart Valves
Polymeric/Next-Gen Heart Valves
By Position
Aortic
Mitral
Tricuspid
Pulmonary
By Delivery Method
Surgical
Transcatheter
Sutureless/Rapid-deployment
By End-User
Hospitals
Cardiac Specialty Centers
Ambulatory Surgical Centers
Leading Companies in Prosthetic Heart Valve Industry (2026)
Edwards Lifesciences Corporation
Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
Livanova PLC
CryoLife, Inc. (Artivion, Inc.)
Meril Life Sciences Pvt. Ltd.
Lepu Medical Technology (Beijing) Co., Ltd.
JenaValve Technology, Inc.
Anteris Technologies Ltd.
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Prosthetic Heart Valve Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Prosthetic Heart Valve Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL PROSTHETIC HEART VALVE MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Prosthetic Heart Valve Markets in 2026
3.2. Global Historic and Forecast Prosthetic Heart Valve Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Prosthetic Heart Valve Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Prosthetic Heart Valve Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Prosthetic Heart Valve Value Chain
CHAPTER 4- PROSTHETIC HEART VALVE MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Prosthetic Heart Valve Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- PROSTHETIC HEART VALVE MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Valve Type
Transcatheter Heart Valves
Mechanical Heart Valves
Tissue/Bioprosthetic Heart Valves
Sutureless Heart Valves
Polymeric/Next-Gen Heart Valves
By Position
Aortic
Mitral
Tricuspid
Pulmonary
By Delivery Method
Surgical
Transcatheter
Sutureless/Rapid-deployment
By End-User
Hospitals
Cardiac Specialty Centers
Ambulatory Surgical Centers
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA PROSTHETIC HEART VALVE MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Prosthetic Heart Valve Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Prosthetic Heart Valve Market Trends and Growth Opportunities to 2034
7.5. North America Prosthetic Heart Valve Market Size Outlook by Type
7.6. North America Prosthetic Heart Valve Market Size Outlook by Application
7.7. North America Prosthetic Heart Valve Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Prosthetic Heart Valve Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Prosthetic Heart Valve Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Prosthetic Heart Valve Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Prosthetic Heart Valve Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Prosthetic Heart Valve Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Prosthetic Heart Valve Companies
CHAPTER 8- EUROPE PROSTHETIC HEART VALVE MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Prosthetic Heart Valve Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Prosthetic Heart Valve Market Trends and Growth Opportunities to 2034
8.5. Europe Prosthetic Heart Valve Market Size Outlook by Type
8.6. Europe Prosthetic Heart Valve Market Size Outlook by Application
8.7. Europe Prosthetic Heart Valve Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Prosthetic Heart Valve Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Prosthetic Heart Valve Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Prosthetic Heart Valve Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Prosthetic Heart Valve Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Prosthetic Heart Valve Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Prosthetic Heart Valve Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Prosthetic Heart Valve Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Prosthetic Heart Valve Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Prosthetic Heart Valve Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Prosthetic Heart Valve Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Prosthetic Heart Valve Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Prosthetic Heart Valve Companies
CHAPTER 9- ASIA PACIFIC PROSTHETIC HEART VALVE MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Prosthetic Heart Valve Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Prosthetic Heart Valve Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Prosthetic Heart Valve Market Size Outlook by Type
9.6. Asia Pacific Prosthetic Heart Valve Market Size Outlook by Application
9.7. Asia Pacific Prosthetic Heart Valve Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Prosthetic Heart Valve Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Prosthetic Heart Valve Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Prosthetic Heart Valve Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Prosthetic Heart Valve Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Prosthetic Heart Valve Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Prosthetic Heart Valve Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Prosthetic Heart Valve Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Prosthetic Heart Valve Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Prosthetic Heart Valve Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Prosthetic Heart Valve Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Prosthetic Heart Valve Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Prosthetic Heart Valve Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA PROSTHETIC HEART VALVE MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Prosthetic Heart Valve Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Prosthetic Heart Valve Market Trends and Growth Opportunities to 2034
10.5. South and Central America Prosthetic Heart Valve Market Size Outlook by Type
10.6. South and Central America Prosthetic Heart Valve Market Size Outlook by Application
10.7. South and Central America Prosthetic Heart Valve Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Prosthetic Heart Valve Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Prosthetic Heart Valve Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Prosthetic Heart Valve Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Prosthetic Heart Valve Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Prosthetic Heart Valve Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Prosthetic Heart Valve Companies
CHAPTER 11- MIDDLE EAST AND AFRICA PROSTHETIC HEART VALVE MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Prosthetic Heart Valve Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Prosthetic Heart Valve Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Prosthetic Heart Valve Market Size Outlook by Type
11.6. Middle East and Africa Prosthetic Heart Valve Market Size Outlook by Application
11.7. Middle East and Africa Prosthetic Heart Valve Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Prosthetic Heart Valve Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Prosthetic Heart Valve Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Prosthetic Heart Valve Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Prosthetic Heart Valve Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Prosthetic Heart Valve Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Prosthetic Heart Valve Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Prosthetic Heart Valve Industry
Edwards Lifesciences Corporation
Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
Livanova PLC
CryoLife, Inc. (Artivion, Inc.)
Meril Life Sciences Pvt. Ltd.
Lepu Medical Technology (Beijing) Co., Ltd.
JenaValve Technology, Inc.
Anteris Technologies Ltd.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Prosthetic Heart Valve Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Prosthetic Heart Valve Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL PROSTHETIC HEART VALVE MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Prosthetic Heart Valve Markets in 2026
3.2. Global Historic and Forecast Prosthetic Heart Valve Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Prosthetic Heart Valve Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Prosthetic Heart Valve Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Prosthetic Heart Valve Value Chain
CHAPTER 4- PROSTHETIC HEART VALVE MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Prosthetic Heart Valve Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- PROSTHETIC HEART VALVE MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Valve Type
Transcatheter Heart Valves
Mechanical Heart Valves
Tissue/Bioprosthetic Heart Valves
Sutureless Heart Valves
Polymeric/Next-Gen Heart Valves
By Position
Aortic
Mitral
Tricuspid
Pulmonary
By Delivery Method
Surgical
Transcatheter
Sutureless/Rapid-deployment
By End-User
Hospitals
Cardiac Specialty Centers
Ambulatory Surgical Centers
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA PROSTHETIC HEART VALVE MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Prosthetic Heart Valve Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Prosthetic Heart Valve Market Trends and Growth Opportunities to 2034
7.5. North America Prosthetic Heart Valve Market Size Outlook by Type
7.6. North America Prosthetic Heart Valve Market Size Outlook by Application
7.7. North America Prosthetic Heart Valve Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Prosthetic Heart Valve Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Prosthetic Heart Valve Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Prosthetic Heart Valve Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Prosthetic Heart Valve Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Prosthetic Heart Valve Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Prosthetic Heart Valve Companies
CHAPTER 8- EUROPE PROSTHETIC HEART VALVE MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Prosthetic Heart Valve Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Prosthetic Heart Valve Market Trends and Growth Opportunities to 2034
8.5. Europe Prosthetic Heart Valve Market Size Outlook by Type
8.6. Europe Prosthetic Heart Valve Market Size Outlook by Application
8.7. Europe Prosthetic Heart Valve Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Prosthetic Heart Valve Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Prosthetic Heart Valve Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Prosthetic Heart Valve Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Prosthetic Heart Valve Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Prosthetic Heart Valve Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Prosthetic Heart Valve Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Prosthetic Heart Valve Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Prosthetic Heart Valve Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Prosthetic Heart Valve Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Prosthetic Heart Valve Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Prosthetic Heart Valve Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Prosthetic Heart Valve Companies
CHAPTER 9- ASIA PACIFIC PROSTHETIC HEART VALVE MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Prosthetic Heart Valve Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Prosthetic Heart Valve Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Prosthetic Heart Valve Market Size Outlook by Type
9.6. Asia Pacific Prosthetic Heart Valve Market Size Outlook by Application
9.7. Asia Pacific Prosthetic Heart Valve Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Prosthetic Heart Valve Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Prosthetic Heart Valve Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Prosthetic Heart Valve Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Prosthetic Heart Valve Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Prosthetic Heart Valve Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Prosthetic Heart Valve Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Prosthetic Heart Valve Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Prosthetic Heart Valve Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Prosthetic Heart Valve Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Prosthetic Heart Valve Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Prosthetic Heart Valve Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Prosthetic Heart Valve Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA PROSTHETIC HEART VALVE MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Prosthetic Heart Valve Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Prosthetic Heart Valve Market Trends and Growth Opportunities to 2034
10.5. South and Central America Prosthetic Heart Valve Market Size Outlook by Type
10.6. South and Central America Prosthetic Heart Valve Market Size Outlook by Application
10.7. South and Central America Prosthetic Heart Valve Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Prosthetic Heart Valve Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Prosthetic Heart Valve Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Prosthetic Heart Valve Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Prosthetic Heart Valve Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Prosthetic Heart Valve Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Prosthetic Heart Valve Companies
CHAPTER 11- MIDDLE EAST AND AFRICA PROSTHETIC HEART VALVE MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Prosthetic Heart Valve Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Prosthetic Heart Valve Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Prosthetic Heart Valve Market Size Outlook by Type
11.6. Middle East and Africa Prosthetic Heart Valve Market Size Outlook by Application
11.7. Middle East and Africa Prosthetic Heart Valve Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Prosthetic Heart Valve Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Prosthetic Heart Valve Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Prosthetic Heart Valve Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Prosthetic Heart Valve Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Prosthetic Heart Valve Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Prosthetic Heart Valve Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Prosthetic Heart Valve Industry
Edwards Lifesciences Corporation
Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
Livanova PLC
CryoLife, Inc. (Artivion, Inc.)
Meril Life Sciences Pvt. Ltd.
Lepu Medical Technology (Beijing) Co., Ltd.
JenaValve Technology, Inc.
Anteris Technologies Ltd.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
